Individuals at high risk for gynecologic cancers, such as those with a family history of breast or ovarian cancer, should consider chemoprevention. Genetic mutations, such as BRCA1 and BRCA2 mutations, also place individuals at higher risk, making them ideal candidates for chemoprevention.
